These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 17070618

  • 1. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA, Beaune P.
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [Abstract] [Full Text] [Related]

  • 2. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S, Fregin A, Hünerberg M, Bevans CG, Müller CR, Oldenburg J.
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [Abstract] [Full Text] [Related]

  • 3. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
    Wallin R, Wajih N, Hutson SM.
    Vitam Horm; 2008 Oct; 78():227-46. PubMed ID: 18374197
    [Abstract] [Full Text] [Related]

  • 4. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hörtnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Müller CR, Strom TM, Oldenburg J.
    Nature; 2004 Feb 05; 427(6974):537-41. PubMed ID: 14765194
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].
    Loriot MA, Beaune P.
    Rev Prat; 2007 Jun 30; 57(12):1281-6. PubMed ID: 17717937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.
    Spohn G, Kleinridders A, Wunderlich FT, Watzka M, Zaucke F, Blumbach K, Geisen C, Seifried E, Müller C, Paulsson M, Brüning JC, Oldenburg J.
    Thromb Haemost; 2009 Jun 30; 101(6):1044-50. PubMed ID: 19492146
    [Abstract] [Full Text] [Related]

  • 9. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R, Hutson SM.
    Trends Mol Med; 2004 Jul 30; 10(7):299-302. PubMed ID: 15242675
    [Abstract] [Full Text] [Related]

  • 10. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.
    Rishavy MA, Hallgren KW, Wilson L, Singh S, Runge KW, Berkner KL.
    Blood; 2018 Jun 21; 131(25):2826-2835. PubMed ID: 29592891
    [Abstract] [Full Text] [Related]

  • 11. [Resistance to coumarin derivatives due to mutated vitamin-K enzyme].
    Hermans MH, Poodt J, van Geest-Daalderop JH, Péquériaux NC, Conemans JM.
    Ned Tijdschr Geneeskd; 2009 Jun 21; 153():A691. PubMed ID: 19857286
    [Abstract] [Full Text] [Related]

  • 12. [Resistance to acenocoumarol revealing a missense mutation of the vitamin K epoxyde reductase VKORC1: a case report].
    Mboup MC, Dia K, Ba DM, Fall PD.
    Ann Cardiol Angeiol (Paris); 2015 Feb 21; 64(1):59-61. PubMed ID: 24095214
    [Abstract] [Full Text] [Related]

  • 13. The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.
    Rishavy MA, Hallgren KW, Wilson LA, Usubalieva A, Runge KW, Berkner KL.
    J Biol Chem; 2013 Nov 01; 288(44):31556-66. PubMed ID: 23918929
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The pharmacogenetics of vitamin K antagonists: still a matter for discussion].
    Moreau C, Siguret V, Loriot MA.
    Rev Med Interne; 2010 May 01; 31(5):361-8. PubMed ID: 20362363
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.
    Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M.
    Thromb Haemost; 2007 Sep 01; 98(3):570-8. PubMed ID: 17849045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.